Search

Displaying results 1271 - 1280 of 10000 in total
  1. Drug

    Diazoxide

    go.drugbank.com/drugs/DB01119
    ApprovedInvestigational

    [A255647,L44612] In March 2025, an extended-release formulation of diazoxide choline was approved by the FDA for the treatment of hyperphagia in patients with Prader-Willi syndrome, becoming the first … [A190372] Diazoxide is commonly used in the treatment of hyperinsulinaemic hypoglycemia due to its ability to inhibit insulin release.

    Categories: combinations of sulfonamides, Arteriolar Smooth Muscle, Agents Acting OnProducts: AZOXID® 50 MG/ML SUSPENSION ORAL, UPGLYCEM® 50 MG/ML. SUSPENSIÓN ORAL
  2. Drug

    Flurbiprofen

    go.drugbank.com/drugs/DB00712
    ApprovedInvestigational

    Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. … Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis.

    Mixtures: KLORHEX PLUS 2.5 MG/ML + 1.2 MG/ML ORAL SPREY, ÇÖZELTİ, 30 ML, FULDUO 100 MG/8 MG FİLM KAPLI TABLET, 14 ADETProducts: Nu-flurbiprofen Tab 50mg, Nu-flurbiprofen Tab 100mg
  3. Drug

    Ferrous sulfate anhydrous

    go.drugbank.com/drugs/DB13257
    ApprovedInvestigational

    [A190804] This type of anemia occurs when iron intake, iron stores, and iron loss do not adequately support the formation of erythrocytes, also known as red blood cells. … [A190528] Ferrous sulfate is a synthetic agent used in the treatment of iron deficiency. It is the gold standard of oral iron therapy in the UK and many other countries.[L2234,L2246]

    Mixtures: Ferrograd - Fol 105 mg / 0,35 mg Filmtabletten, GYNOTARDYFERON 80 MG/0,35 MG UZATILMIŞ SALIMLI KAPLI TABLET, 30 ADETProducts: Tardyferon 80 mg Retardtabletten, Ferro - Gradumet 105 mg Filmtabletten
  4. Drug

    Desloratadine

    go.drugbank.com/drugs/DB00967
    ApprovedInvestigational

    It is the active descarboethoxy metabolite of loratidine (a second generation histamine).

    Mixtures: AIRCOMB 2,5 MG/4 MG GRANÜL İÇEREN SAŞE, 30 ADET, AIRCOMB 2,5 MG/4 MG GRANÜL İÇEREN SAŞE, 90 ADETProducts: DELODAY 0,5 MG/MG SURUP, 150 ML, AERIUS 2.5 MG
  5. Drug

    Inulin

    go.drugbank.com/drugs/DB00638
    ApprovedInvestigationalNutraceutical

    It has been used in physiologic investigation for determination of the rate of glomerular function. … A starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Cipepofol

    go.drugbank.com/drugs/DB16295
    ApprovedInvestigational

    regulatory history outside the United States: China's National Medical Products Administration approved it in December 2020 under the trade name Sishuning, and its Chinese label has since expanded to cover … of anesthetics while reducing the injection pain and respiratory depression that have long been recognized as limitations of intravenous anesthesia.

  7. Drug

    Vosoritide

    go.drugbank.com/drugs/DB11928
    ApprovedInvestigational

    of a condition like achondroplasia. … Vosoritide is an analog of CNP with proline-glycine on its N-terminus to convey resistance to neutral endopeptidase.

    Categories: Drugs for Treatment of Bone Diseases
  8. Drug

    Technetium Tc-99m etidronate

    go.drugbank.com/drugs/DB09411
    Approved

    Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household setting
  9. Drug

    Rasagiline

    go.drugbank.com/drugs/DB01367
    ApprovedInvestigational

    Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.

    Categories: Compounds used in a research, industrial, or household setting, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: AZILECT 1 MG, Ag-rasagiline
  10. Drug

    Brigatinib

    go.drugbank.com/drugs/DB12267
    ApprovedInvestigational

    [A31313] Brigatinib was developed by Ariad Pharmaceuticals, a subsidiary of Takeda Pharmaceutical Company Limited, and FDA-approved on April 28, 2017.[L1026] … It presents selectivity against the mutant forms of EGFR compared to the wild-type.

    Mixtures: ALUNBRİG 90 MG VE 180 MG FİLM KAPLI TABLET TEDAVİYE BAŞLANGIÇ PAKETİ, 7 ADET 90 MG VE 21 ADET 180 MG, ALUNBRİG 90 MG VE 180 MG FİLM KAPLI TABLET TEDAVİYE BAŞLANGIÇ PAKETİ, 7 ADET 90 MG VE 21 ADET 180 MGProducts: ALUNBRIG 30 MG, ALUNBRIG 90 MG